相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical Outcomes and Safety of Apatinib Mesylate in the Treatment of Advanced Non-Squamous Non-Small Cell Lung Cancer in Patients Who Progressed After Standard Therapy and Analysis of the KDR Gene Polymorphism
Zi-Zheng Song et al.
ONCOTARGETS AND THERAPY (2020)
Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances
Alphonse E. Sirica et al.
HEPATOLOGY (2019)
Synergistic anti-tumour effects of Clostridium butyricum in combination with apatinib in CT26 colorectal tumour-bearing mice
Meng Xin et al.
ANTI-CANCER DRUGS (2019)
FGFR2 genomic aberrations: Achilles heel in the management of advanced cholangiocarcinoma
Amit Mahipal et al.
CANCER TREATMENT REVIEWS (2019)
Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial
C. Morizane et al.
ANNALS OF ONCOLOGY (2019)
Molecular pathogenesis of gallbladder cancer: An update
Shravan Kumar Mishra et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2019)
Efficacy And Safety Of Apatinib Treatment In Platinum-Resistant Recurrent Epithelial Ovarian Cancer: A Real World Study
Jindi Zhang et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2019)
Targeting phosphoinositide-3-kinase pathway in biliary tract cancers: A remedial route?
Jayaramayya Kaavya et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Biliary tract cancer: current challenges and future prospects
Michele Ghidini et al.
CANCER MANAGEMENT AND RESEARCH (2019)
A randomised phase II study of second-line XELIRI regimen versus irinotecan monotherapy in advanced biliary tract cancer patients progressed on gemcitabine and cisplatin
Yi Zheng et al.
BRITISH JOURNAL OF CANCER (2018)
Efficacy and safety of apatinib monotherapy in advanced bone and soft tissue sarcoma: An observational study
Baorang Zhu et al.
CANCER BIOLOGY & THERAPY (2018)
Immunotherapy as a treatment for biliary tract cancers: A review of approaches with an eye to the future
Alex B. Blair et al.
CURRENT PROBLEMS IN CANCER (2018)
Genetic landscape of gallbladder cancer: Global overview
Ravi Mehrotra et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2018)
The Efficacy and Safety of Apatinib Treatment for Patients with Unresectable or Relapsed Liver Cancer: a retrospective study
Liu Zhen et al.
JOURNAL OF CANCER (2018)
Apatinib affect VEGF-mediated cell proliferation, migration, invasion via blocking VEGFR2/RAF/MEK/ERK and PI3K/AKT pathways in cholangiocarcinoma cell
Manping Huang et al.
BMC GASTROENTEROLOGY (2018)
Apatinib for treating advanced intrahepatic cholangiocarcinoma after failed chemotherapy A case report and literature review
Li-Ye Wang et al.
MEDICINE (2018)
New Horizons for Precision Medicine in Biliary Tract Cancers
Juan W. Valle et al.
CANCER DISCOVERY (2017)
Randomized Phase III study of gemcitabine plus S-1 versus gemcitabine plus cisplatin in advanced biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1113, FUGA-BT)
Junki Mizusawa et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2016)
Molecular genetics and targeted therapeutics in biliary tract carcinoma
Eric I. Marks et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Apatinib inhibits VEGF signaling and promotes apoptosis in intrahepatic cholangiocarcinoma
Hong Peng et al.
ONCOTARGET (2016)
Targeted therapy in cancer
Apostolia-Maria Tsimberidou
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2015)
Optimum chemotherapy for the management of advanced biliary tract cancer
Marwan Ghosn et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer.
Juan Valle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
The epidemiology of cholangiocarcinoma
Y Shaib et al.
SEMINARS IN LIVER DISEASE (2004)
分享论文
